Emergent BioSolutions Inc. EBS
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Emergent BioSolutions Inc. is a global life sciences company that primarily focuses on the development, manufacturing, and distribution of a wide array of medical products. These products are designed to address public health threats including chemical and biological agents, and infectious diseases. As an important pla…
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees900
TickerEBS
Statistics
Market Cap$421.7M
Revenue (TTM)$742.9M
Net Income$52.6M
Net Margin7.1%
EPS$0.93
P/E8.59
P/S0.64
P/B0.83
EV/EBITDA5.10
ROE-1.6%
Dividend Yield—
Price$8.14
Data: Twelve Data · Revenue = mcap / P/S